We describe a genetic selection method designed to facilitate the cloning of genes encoding sequencespecific DNA-binding proteins. The strategy selects for clones expressing particular sequence-specific DNA-binding activities from a library of clones encoding other, nonspecific proteins. Specific DNA-binding sites have been placed near the start of transcription of the strong synthetic conH promoter to create promoters that can be repressed by the corresponding sequence-specific DNA-binding proteins. Transcription from the conH derivatives in the absence of repression interferes with the phenotypic expression of an adjacent drug-resistance gene, aadA. Sequence-specific DNA-binding proteins are shown to repress these promoters and alleviate transcriptional interference of aadA, resulting in drug resistance in cells expressing the appropriate DNA-binding protein.
Gene expression is primarily regulated at the level of interactions between cis-acting control sequences and their corresponding sequence-specific recognition proteins. The identification of cis-acting regulatory sequences has become fairly routine in the last decade. Likewise, the identification of sequence-specific DNA-binding proteins that interact with these sequences in vitro has also accelerated. These advances have relied primarily on several methods to measure in vitro binding of proteins to DNA, such as nitrocellulose filter binding (1) , DNase I protection ("footprinting") (2) , and electrophoretic mobility retardation (3) . Identifying the genes that encode these sequence-specific DNA-binding proteins, especially those from higher eukaryotes, has proven to be a more difficult task. The strategy typically employed involves the purification of the protein, followed by the preparation of antibody probes or by protein sequence determination to generate nucleic acid probes (4) . These probes are then used to screen the appropriate libraries for the gene of interest. A recent, less arduous approach to cloning genes encoding sequence-specific DNA-binding proteins has been to screen expression libraries by using labeled specific DNAs as ligands (5) . This direct screening procedure should facilitate the isolation of regulatory genes, although it relies on the production of a functional protein that retains its DNAbinding capacity when bound to a nitrocellulose filter. This requirement may preclude identification of certain classes of DNA-binding activities.
Identification methods that involve the screening of libraries are inherently limited in their ability to isolate cDNAs present in low abundance. An identification strategy utilizing a selection method can increase the sensitivity for detection of rare clones by several orders of magnitude, thus allowing one to take advantage of larger expression libraries being produced by advances in cloning technologies. Several DNAbinding proteins from eukaryotes-e.g., GAL4 (6) , FLP (7) , and Spl (4)-have been shown to function as repressors when expressed in bacteria. Based on these observations we developed a genetic selection for isolating clones that express binding proteins corresponding to specific DNA sequences. The utility of this method is contingent upon the assumption that, in general, other eukaryotic DNA-binding proteins, when expressed in Escherichia coli, will retain their DNAbinding capacity. A selection scheme based on these considerations has been developed for Salmonella typhimurium (8) , an organism that is less well suited to the introduction of large expression libraries and other genetic manipulations than E. coli. Our selection utilizes E. coli and is derived from the transcriptional interference assay described by Elledge and Davis (9) .
MATERIALS AND METHODS
Bacteria, Plasmids, and Genetic Techniques. E. coli JM106 was used as the lacIZ-host for the lacI selection experiments. CY15075 (W3110 tna2, AlacU169, trpR2) (10) was used as the trpR host. JM109 (JM107 recA-) was used as the host for the Epstein-Barr virus nuclear antigen 1 (EBNA-1) selection experiments. Plasmid pRPG9 (9) was a gift from M. Kuroda. pMC9 (11) was a gift from M. Calos. pKB280 (12) was a gift from K. Bachman. pNN386, pNN387, and pNN388 were constructed as described (9 Construction of Regulated Promoters and Plasmids. Construction of conI-1 and conII-2 was described previously (9) . The reporter plasmid for the genetic selection of the A repressor (cI) was made in two steps. First, a blunt-ended Pst I double-stranded oligonucleotide representing OR1, of sequence 5'-TTACCTCTGGCGGTGATATGCA-3' (bold letters represent the double-stranded region), was cloned into Sma I/Pst I-cut pNN396. This places the left edge of OR1 at +2 relative to the start of transcription, creating conII-10, pNN397. Then the Not 1-HindIII promoter-ORi-containing fragment was cloned into Not I/HindIII-cleaved pNN388. This plasmid, pNN398, confers the CmrSps phenotype. The reporter plasmid for the selection of EBNA-1 was constructed in two steps also. First, a double-stranded oligonucleotide containing a single oriP sequence was synthesized with BamHI-compatible ends. The top strand was 5'-Abbreviations: EBNA-1, Epstein-Barr virus nuclear antigen 1; Cm, chloramphenicol; Sp, spectinomycin; Ap, ampicillin.
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GATCAGATTAGGATAGCATATGCTACCCAGATA-3' and the bottom strand was 5'-GATCTATCTGGGTAG-CATATGCTATCCTAATCT-3' (the overlapping region that is double-stranded when the oligonucleotides are hybridized is shown in bold type). This double-stranded oligonucleotide was ligated into BamHI-cleaved pNN396. A clone was chosen, pNN399, which contained two tandem copies of the oligonucleotide arranged in direct repeats. Then the Not IHindIII promoter-oriP-containing fragment was cloned into Not I/HindIII-cleaved pNN388 to create pNN400.
RESULTS AND DISCUSSION
The General Selection Scheme for Sequence-Specific DNABinding Activities. Elledge and Davis (9) Preg, a regulated promoter that interferes with the phenotypic expression of aadA; when transcription from Preg is not repressed, the cell will be SpS. PaadA represents the promoter for aadA. If, after introduction of an expression library, there exists a plasmid clone (represented by an open circle) that produces a protein (represented by the filled circles) that specifically recognizes the Op site, then the Preg promoter will be repressed. This diminishes transcriptional interference and permits expression of the aadA gene as depicted by the longer transcription arrow. The cell containing the plasmid encoding the cognate DNA-binding protein becomes Spr. pNN388 (9) . The sequences of these promoters are shown in Fig. 2 . The repressor-encoding plasmids were introduced by transformation into their respective reporter strains and the frequencies of drug-resistant transformants were measured ( Table 1) .
The data in Table 1 show that the ability to activate aadA is specific for the plasmid encoding the cognate sequencespecific DNA-binding protein (compare pMC9 and pRPG9 effects on conII-2). The vector alone (pBR322 or pUC8) did not confer Spr upon the host. The number of transformants within a cognate pair that survive a double Ap Sp selection is slightly lower than the number that survive Ap alone, even though all Apr colonies are Spr when the selections are applied sequentially.
Many eukaryotic transcription factors are thought to bind DNA weakly and rely on multiple binding sites and cooperativity to function in their normal environments. The bacteriophage A repressor, encoded by the cI gene, is a prokaryotic gene that shares these properties. Therefore, the A cI gene Pseudolinkage to Spr was tested by transformation. After heat shock, cells were incubated in LB broth while shaking for 1-1.5 hr at 370C to allow expression of the DNA-binding protein before plating. The transformation recipient for the pRPG9 selection was CY15075 bearing the conll-2 derivative of pNN388. The transformation recipient for pMC9 was the conl-l derivative of pNN388 (9) in JM106. The transformation recipient for pKB280 was the conII-10 derivative of pNN388 in JM107. Agtll was lysogenized into the same strain to test for the ability of a single copy of cI857 to be selected. Lysogens were selected by infecting at a multiplicity of infection of 2 in LB broth plus 10 mM MgCl2 for 1 hr at 30'C. Cells were then plated on LB agar plates spread with 0.1 ml of Acl-h8O (109 plaque-forming units) and incubated overnight at 30'C. Colonies that grew were tested for A immunity by cross-streaking with wild-type A at 30'C and were checked for temperature sensitivity at 42'C. *Values are normalized to the number of Apr transformants. tThese percentages were calculated by replica-plating the Apr transformants after 1 day of growth on plates containing Sp or Cm. AprCms colonies were subtracted from the Apr total in this calculation. Approximately 400 colonies were screened for each transformation.
tThis value represents a normalization to AcI-h8-resistant, temperature-sensitive transductants as described in the legend.
product was tested for DNA-binding activity in this assay. A single copy of the A cI gene, provided by lysogenizing the tester strain with Agtll, is insufficient to provide Spr with the conII-10 assay promoter (Table 1) . However, pKB280, an overproducer of A repressor (12) , can confer Spr on the tester strain. This experiment demonstrates that even weak DNAbinding proteins that normally rely on multiple binding sites and cooperativity can be selected in this assay by increasing their levels in the cell.
Eukaryotic DNA-Binding Proteins Can Also Be Selected in the Spr Assay. EBNA-1 was selected as a model eukaryotic DNA-binding protein to test for DNA-binding in this assay. EBNA-1 is required for maintenance of the Epstein-Barr virus genome as an autonomously replicating plasmid in human cell lines and is also a transactivator of viral gene expression (13) . The carboxyl-terminal third of EBNA-1 has been expressed in E. coli as a fusion protein from the plasmid pNAK28 and shown to encode a sequence-specific DNAbinding protein (14, 15) . We constructed the test promoter conII-11 ( Fig. 2) A successful strategy for operator positioning has been to place the leftmost edge of an operator near the start of transcription, between positions -5 and +5 (9) . Proteins that bind DNA very tightly, such as Lac-I and EBNA-1, can efficiently repress when placed further away from the start of transcription than +5, but weaker binding proteins such as Trp-R can only repress efficiently when located closer to the start of transcription (9) . Approximately 95% of all sequences placed in this context retain sufficient promoter strength to function in the assay (data not shown). It is known that sequences in the transcribed region can contribute to promoter strength (16) , but the rules governing these effects are still unknown. Genetics: Elledge et al.
To construct a regulated promoter, an oligonucleotide containing the binding site is synthesized with ends that will facilitate subcloning into the assay promoter. When designing the oligonucleotide, an attempt is made to define the sequence such that a purine, preferably an adenine or a stretch of adenines, is located at position + 1, although this is clearly not essential since the conII-10 promoter has only pyrimidines from -2 to +3 and it is fully functional in this assay.
Assay promoters carrying substituted binding sites are constructed in two steps as shown in Fig. 3 . First, sites are synthesized and cloned into pNN396, which contains the conII promoter. Typically, pNN396 is cut with Kpn I or Asp718 and made flush-ended with T4 DNA polymerase to prepare a blunt site at position -5 or -1, respectively. This molecule is then cleaved with Pst I and purified by agarose gel electrophoresis. It is then ligated to the synthetic doublestranded oligonucleotide, which was designed to possess one flush end and one Pst I-compatible end.
Oligonucleotide-containing subclones should be sequenced to verify their structure. This is easily accomplished because pNN396 contains a phage fl origin. After properly modified promoters have been created, they can be placed into the transcriptional interference assay vector pNN388 by using Not I and HindIII restriction enzymes (Fig. 3) . These constructs should convert the CmrSpr pNN388 into a CmrSps derivative.
After choosing the best operator sequence to function in this assay, choosing the proper vector for the construction of the expression library is the most critical decision. It is clear that higher levels of functional binding protein will result in more efficient repression, as observed for A cI in Table 1 Conclusions. We have demonstrated the feasibility of a genetic selection scheme based on a transcriptional interference assay to isolate clones that express proteins that bind to specific DNA sequences. This selection can be employed in a transformation procedure to specifically enrich for molecules encoding the proper sequence-specific binding protein in a mixture of molecules encoding nonspecific proteins. We have shown that both prokaryotic and eukaryotic DNAbinding proteins can be detected by this assay. The advantageous features of this system are that (i) it functions in E. coli and is therefore relatively quick and easy; (ii) it has a low background reversion frequency, and multiple rounds of selection can be used to purify rare clones; (iii) it is compatible with existing A-based cDNA expression vectors as well as plasmid vectors; (iv) the binding site is present on a single-copy plasmid or the chromosome, thereby minimizing the number of molecules of binding protein needed; (v) it is extremely sensitive, requiring DNA-binding proteins in concentrations that give only 4-fold repression (9) ; (vi) Sp levels may be adjusted to select for minimal or maximal levels of repression; (vii) relatively small proteins that bind DNA weakly can be selected with this system; and (viii) extremely large libraries can be completely screened.
This selection scheme has certain limitations. Eukaryotic DNA-binding proteins that require posttranslational modifications absent from E. coli will be difficult to isolate, as will binding functions requiring two different polypeptides for activity (21) . Factors that have a short recognition sequence (7 base pairs or less) will be difficult to identify because sites identical to the recognition sequence are present on the E. coli chromosome and will compete efficiently with the site on the assay plasmid.
This assay is also useful once a gene has been isolated. It can be used to rapidly identify mutations in the gene and to select revertants of these mutations. Having a functional assay in E. coli will also greatly facilitate the structurefunction analysis of the gene. Further, this assay may be used to select for novel binding specifities.
We feel that this genetic selection, along with the other recently developed screens for identification of sequencespecific DNA-binding proteins, has set the stage for the systematic isolation of eukaryotic DNA-binding proteins from expression libraries. The critical task that lies ahead is the production of large cDNA expression libraries of high quality in easy-to-manipulate expression vectors.
